Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2026.3.2.
Saved in:
| Title: | Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2026.3.2. |
|---|---|
| Authors: | Puri S; Moffitt Cancer Center, Tampa, FL, US., Ismaila N; American Society of Clinical Oncology (ASCO), Alexandria, VA, US., Azar IH; IHA Hematology Oncology Consultants, Ypsilanti, MI, US., Freeman-Daily J; The ROS1ders, Seattle, WA, US., Furuya N; St. Marianna University School of Medicine, Kawasaki, Japan., Kuruvilla S; London Health Sciences Centre, London, ON, Canada., Roof L; Ohio State University, Columbus, OH, US., Velazquez AI; University of California, San Francisco, CA, US., Wang Y; Lovelace Cancer Care, Albuquerque, NM, US., Wheatley Price P; The Ottawa Hospital Research Institute/University of Ottawa, Ottawa, ON, Canada., Leighl NB; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada. |
| Source: | Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2026 Jun 29, pp. 101200JCO2601479. Date of Electronic Publication: 2026 Jun 29. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1527-7755 |
|---|---|
| DOI: | 10.1200/JCO-26-01479 |
